Brief: TCR2 Therapeutics Says Ceasing Manufacturing Operations At Facility In Stevenage, UK

TCR2 Therapeutics

01/11/2021 21:41

Nov 1 (Reuters) - TCR2 Therapeutics Inc  TCRR.O :
    * TCR2 THERAPEUTICS INC -  CEASING MANUFACTURING OPERATIONS
AT
CO'S FACILITY IN STEVENAGE, UK COULD AFFECT AN ESTIMATED 34
EMPLOYEES IN UK
    * TCR2 THERAPEUTICS INC - SHOULD CO PROCEED WITH PROPOSAL,
EXPECTS
TO REDUCE ANNUAL OPERATING EXPENSES IN 2022 BY ABOUT $16 MILLION
    * TCR2 THERAPEUTICS INC - SHOULD CO PROCEED WITH PROPOSAL,
EXPECTS
TO INCUR PRE-TAX RESTRUCTURING CHARGES IN Q4 2021 OF ABOUT $4.0
TO $4.5 MILLION

Source text: (https://bit.ly/3q5En4S) 
Further company coverage:  TCRR.O 

 ((Reuters.Briefs@thomsonreuters.com;))